It's been a tough year for everyone, both professionally and personally. @CovidSurg's priority has been to support surgeons & anaesthetists by providing these best possible evidence to inform surgical care during the pandemic.
As the pandemic has progressed, we constantly re-prioritised
Our global team worked hard to engage colleagues around the work.
@CovidSurg's work has only been possible through the enthusiasm and dedication of >18,000 collaborators across >2,000 hospitals in 120 countries.
We are very grateful everyone who has contributed - thank you!
We completed three separate cohort studies in 2020; compressing workflows that usually take years in to months.
The speed of delivery and publication was made possible by massive teams working cohesively - thank you to our core operations & dissemination committees!
For each of our publications, our Dissemination Committee has focussed on sharing our research findings as widely, as possible with surgeons, anaesthetists and patients.
This is reflected in:
>Altmetrics
>Citations
>Media coverage
>Informing guidelines
We also worked with patient groups to create dedicated patient resources in a variety of formats and languages: nihrglobalsurgery.org/surgeryduringc…
These resources cover
▶️Effects of COVID-19 on surgical patients
▶️What the hospital is doing to keep you safe
▶️What you can do to stay safe
Over the next six months we will continue working to analyse the data we collected in 2020 and to disseminate our findings as rapidly as possible.
If you would like to receive updates on our work, please join our Telegram group - link: t.me/covidsurg
We proudly share the first @CovidSurg@GlobalSurg paper published in @Anaes_Journal based on the world’s biggest data about surgery following SARS-CoV-2 infection. Hopefully, it will guide practice.
@CovidSurg@GlobalSurg Week was an international, prospective cohort study with more than 140,000 surgical patients from 116 countries enrolled 🌏🌎🌍
We compared 30-day postoperative mortality in previously infected patients with SARS-CoV-2 vs patients who never were infected
Previously infected patients having surgery at 0-2, 3-4, 5-6 weeks after the infection have higher mortality rates than patients who never got infected with SARS-CoV-2